InMed Pharmaceuticals Inc. (NASDAQ: INM) Stock Information | RedChip

InMed Pharmaceuticals Inc. (NASDAQ: INM) Listen to this Section


$0.15
+0.0042 ( +2.98% ) 89.9K

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Market Data


Open


$0.15

Previous close


$0.14

Volume


89.9K

Market cap


$1.33M

Day range


$0.14 - $0.15

52 week range


$0.12 - $2.08

Insider Ownership Transactions

Total Amount Purchased: 75,825.00 | $ 10,994.63

Date Type Amount Purchased Purchaser
2024-08-02 Sale -240.00 MANCINI ALEXANDRA DIANE JANET
2024-05-28 Sale -1139.00 ADAMS ERIC A
2024-05-28 Sale -545.00 HSU ERIC C
2024-05-28 Sale -485.00 MANCINI ALEXANDRA DIANE JANET
2024-05-28 Sale -394.00 WOUDENBERG MICHAEL
2024-03-05 Sale -121.00 MANCINI ALEXANDRA DIANE JANET
2024-03-05 Sale -309.00 HSU ERIC C
2024-03-05 Sale -42.00 HULL ANDREW
2024-02-22 Buy 37500.00 HULL ANDREW
2024-02-21 Buy 41600.00 ADAMS ERIC A

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 02, 2024
8-k 8K-related 15 Jul 30, 2024
8-k 8K-related 16 Jun 28, 2024
8-k 8K-related 15 Jun 11, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
10-q Quarterly Reports 76 May 14, 2024
8-k 8K-related 15 May 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.